{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:01:40Z","timestamp":1762898500497},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10822-009-9269-0","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T14:06:01Z","timestamp":1241618761000},"page":"555-569","source":"Crossref","is-referenced-by-count":10,"title":["Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors"],"prefix":"10.1007","volume":"23","author":[{"given":"Rafael","family":"Gozalbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Mosul\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo J.","family":"Carbajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pineda-Lucena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"issue":"11","key":"9269_CR1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s00018-008-7584-6","volume":"65","author":"NJ Nasser","year":"2008","unstructured":"Nasser NJ (2008) Heparanase involvement in physiology and disease. Cell Mol Life Sci 65(11):1706\u20131715. doi: 10.1007\/s00018-008-7584-6","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"9269_CR2","doi-asserted-by":"crossref","first-page":"e2319","DOI":"10.1371\/journal.pone.0002319","volume":"3","author":"F Levy-Adam","year":"2008","unstructured":"Levy-Adam F, Feld S, Suss-Toby E et al (2008) Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans. PLoS One 3(6):e2319. doi: 10.1371\/journal.pone.0002319","journal-title":"PLoS One"},{"issue":"12","key":"9269_CR3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","volume":"38","author":"N Ilan","year":"2006","unstructured":"Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38(12):2018\u20132039. doi: 10.1016\/j.biocel.2006.06.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"20","key":"9269_CR4","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2174\/138161207781039742","volume":"13","author":"I Vlodavsky","year":"2007","unstructured":"Vlodavsky I, Ilan N, Naggi A et al (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13(20):2057\u20132073. doi: 10.2174\/138161207781039742","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9269_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","volume":"108","author":"I Vlodavsky","year":"2001","unstructured":"Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108(3):341\u2013347","journal-title":"J Clin Invest"},{"issue":"51","key":"9269_CR6","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1021\/bi002080p","volume":"39","author":"MD Hulett","year":"2000","unstructured":"Hulett MD, Hornby JR, Ohms SJ et al (2000) Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 39(51):15659\u201315667. doi: 10.1021\/bi002080p","journal-title":"Biochemistry"},{"issue":"1","key":"9269_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2004.tb00127.x","volume":"22","author":"LM Khachigian","year":"2004","unstructured":"Khachigian LM, Parish CR (2004) Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies. Cardiovasc Drug Rev 22(1):1\u20136","journal-title":"Cardiovasc Drug Rev"},{"key":"9269_CR8","volume-title":"New developments in therapeutic glycomics","author":"E Hammond","year":"2006","unstructured":"Hammond E, Bytheway I, Ferro V (2006) Heparanase as a target for anticancer therapeutics: new developments and future prospects. In: Delehedde M, Lortat-Jacob H (eds) New developments in therapeutic glycomics. Research Signpost, Kerala, India"},{"key":"9269_CR9","unstructured":"G\u00fcner OF (2000) Pharmacophore perception, development, and use in drug design. International University Line, La Jolla, California"},{"issue":"12","key":"9269_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/1568026023392940","volume":"2","author":"OF G\u00fcner","year":"2002","unstructured":"G\u00fcner OF (2002) History and evolution of the pharmacophore concept in computer-aided drug design. Curr Top Med Chem 2(12):1321\u20131332. doi: 10.2174\/1568026023392940","journal-title":"Curr Top Med Chem"},{"issue":"1\u20132","key":"9269_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drudis.2007.09.007","volume":"13","author":"G Wolber","year":"2008","unstructured":"Wolber G, Seidel T, Bendix F et al (2008) Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discov Today 13(1\u20132):23\u201329. doi: 10.1016\/j.drudis.2007.09.007","journal-title":"Drug Discov Today"},{"key":"9269_CR12","first-page":"385","volume":"33","author":"CG Wermuth","year":"1998","unstructured":"Wermuth CG, Ganellin CR, Lindberg P et al (1998) Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1997). Annu Rep Med Chem 33:385\u2013395. doi: 10.1016\/S0065-7743(08)61101-X","journal-title":"Annu Rep Med Chem"},{"issue":"23","key":"9269_CR13","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/jm0608356","volume":"49","author":"N Huang","year":"2006","unstructured":"Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49(23):6789\u20136801. doi: 10.1021\/jm0608356","journal-title":"J Med Chem"},{"issue":"19","key":"9269_CR14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","volume":"8","author":"M Congreve","year":"2003","unstructured":"Congreve M, Carr R, Murray C et al (2003) A \u2018rule of three\u2019 for fragment-based lead discovery? Drug Discov Today 8(19):876\u2013877. doi: 10.1016\/S1359-6446(03)02831-9","journal-title":"Drug Discov Today"},{"issue":"4","key":"9269_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1013302231549","volume":"21","author":"C Dalvit","year":"2001","unstructured":"Dalvit C, Fogliatto G, Stewart A et al (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 21(4):349\u2013359. doi: 10.1023\/A:1013302231549","journal-title":"J Biomol NMR"},{"key":"9269_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jmra.1995.1047","volume":"112","author":"T-L Hwang","year":"1995","unstructured":"Hwang T-L, Shaka AJ (1995) Water suppression that works: excitation sculpting using arbitrary waveforms and pulse field gradients. J Magn Reson A 112:275\u2013279. doi: 10.1006\/jmra.1995.1047","journal-title":"J Magn Reson A"},{"issue":"8","key":"9269_CR17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","volume":"42","author":"B Meyer","year":"2003","unstructured":"Meyer B, Peters T (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed Engl 42(8):864\u2013890. doi: 10.1002\/anie.200390233","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"9269_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm701020f","volume":"51","author":"C Ludwig","year":"2008","unstructured":"Ludwig C, Michiels PJA, Wu X et al (2008) SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy. J Med Chem 51(1):1\u20133. doi: 10.1021\/jm701020f","journal-title":"J Med Chem"},{"issue":"2","key":"9269_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1747-0285.2008.00768.x","volume":"73","author":"BJ Stockman","year":"2009","unstructured":"Stockman BJ, Kothe M, Kohls D et al (2009) Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H\u201315N TROSY experiments. Chem Biol Drug Des 73(2):179\u2013188. doi: 10.1111\/j.1747-0285.2008.00768.x","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"9269_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1039\/B709658P","volume":"132","author":"J Klages","year":"2007","unstructured":"Klages J, Coles M, Kessler H (2007) NMR-based screening: a powerful tool in fragment-based drug discovery. Analyst 132(7):693\u2013705. doi: 10.1039\/b709658p","journal-title":"Analyst"},{"issue":"23\u201324","key":"9269_CR21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.drudis.2007.08.005","volume":"12","author":"G Siegal","year":"2007","unstructured":"Siegal G, Ab E, Schultz J (2007) Integration of fragment screening and library design. Drug Discov Today 12(23\u201324):1032\u20131039. doi: 10.1016\/j.drudis.2007.08.005","journal-title":"Drug Discov Today"},{"issue":"4","key":"9269_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/ci00008a012","volume":"32","author":"M Petitjean","year":"1992","unstructured":"Petitjean M (1992) Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J Chem Inf Comput Sci 32(4):331\u2013337. doi: 10.1021\/ci00008a012","journal-title":"J Chem Inf Comput Sci"},{"key":"9269_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnmrs.2007.07.002","volume":"51","author":"C Dalvit","year":"2007","unstructured":"Dalvit C (2007) Ligand- and substrate-based 19F NMR screening: principles and applications to drug discovery. Prog Nucl Magn Reson Spectrosc 51:243\u2013271. doi: 10.1016\/j.pnmrs.2007.07.002","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"12","key":"9269_CR24","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1021\/ja0772041","volume":"130","author":"H Ji","year":"2008","unstructured":"Ji H, Stanton BZ, Igarashi J et al (2008) Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J Am Chem Soc 130(12):3900\u20133914. doi: 10.1021\/ja0772041","journal-title":"J Am Chem Soc"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-009-9269-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9269-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:23:00Z","timestamp":1559265780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-009-9269-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9269"],"URL":"https:\/\/doi.org\/10.1007\/s10822-009-9269-0","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]}}}